Chart Master advises caution on Pfizer stock purchases, citing its current 52-week low. In-depth Pfizer PFE stock analysis explores investment options, comparing high-yield Pfizer with higher-growth Merck. Trade Tracker Josh Brown's recent Pfizer buy adds to the discussion. Investors should weigh risks and rewards before making decisions.